View in EDS HTML Full Text PDF Full Text

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Saved in:
Bibliographic Details
Title: Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Authors: Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu., Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA., Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA., Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA., Manam M; Boston Children's Hospital, Boston, MA, USA., MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA., Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA., Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA., Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA., Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lindeman NI; Weill Cornell Medical College, New York, NY, USA., Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Cherniack AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
Source: Nature communications [Nat Commun] 2024 Aug 22; Vol. 15 (1), pp. 7218. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39174503
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Forrest+SJ%22">Forrest SJ</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Gupta+H%22">Gupta H</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ward+A%22">Ward A</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+YY%22">Li YY</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Doan+D%22">Doan D</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Al-Ibraheemi+A%22">Al-Ibraheemi A</searchLink>; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Alexandrescu+S%22">Alexandrescu S</searchLink>; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bandopadhayay+P%22">Bandopadhayay P</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shusterman+S%22">Shusterman S</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mullen+EA%22">Mullen EA</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Collins+NB%22">Collins NB</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chi+SN%22">Chi SN</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wright+KD%22">Wright KD</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kumari+P%22">Kumari P</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mazor+T%22">Mazor T</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ligon+KL%22">Ligon KL</searchLink>; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shivdasani+P%22">Shivdasani P</searchLink>; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Manam+M%22">Manam M</searchLink>; Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22MacConaill+LE%22">MacConaill LE</searchLink>; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ceca+E%22">Ceca E</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Benich+SN%22">Benich SN</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22London+WB%22">London WB</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schilsky+RL%22">Schilsky RL</searchLink>; American Society of Clinical Oncology, Alexandria, VA, USA.<br /><searchLink fieldCode="AU" term="%22Bruinooge+SS%22">Bruinooge SS</searchLink>; American Society of Clinical Oncology, Alexandria, VA, USA.<br /><searchLink fieldCode="AU" term="%22Guidry+Auvil+JM%22">Guidry Auvil JM</searchLink>; National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Cerami+E%22">Cerami E</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rollins+BJ%22">Rollins BJ</searchLink>; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meyerson+ML%22">Meyerson ML</searchLink>; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lindeman+NI%22">Lindeman NI</searchLink>; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+BE%22">Johnson BE</searchLink>; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cherniack+AD%22">Cherniack AD</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Church+AJ%22">Church AJ</searchLink>; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Janeway+KA%22">Janeway KA</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 22; Vol. 15 (1), pp. 7218. <i>Date of Electronic Publication: </i>2024 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39174503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-51184-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7218
    Titles:
      – TitleFull: Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Forrest SJ
      – PersonEntity:
          Name:
            NameFull: Gupta H
      – PersonEntity:
          Name:
            NameFull: Ward A
      – PersonEntity:
          Name:
            NameFull: Li YY
      – PersonEntity:
          Name:
            NameFull: Doan D
      – PersonEntity:
          Name:
            NameFull: Al-Ibraheemi A
      – PersonEntity:
          Name:
            NameFull: Alexandrescu S
      – PersonEntity:
          Name:
            NameFull: Bandopadhayay P
      – PersonEntity:
          Name:
            NameFull: Shusterman S
      – PersonEntity:
          Name:
            NameFull: Mullen EA
      – PersonEntity:
          Name:
            NameFull: Collins NB
      – PersonEntity:
          Name:
            NameFull: Chi SN
      – PersonEntity:
          Name:
            NameFull: Wright KD
      – PersonEntity:
          Name:
            NameFull: Kumari P
      – PersonEntity:
          Name:
            NameFull: Mazor T
      – PersonEntity:
          Name:
            NameFull: Ligon KL
      – PersonEntity:
          Name:
            NameFull: Shivdasani P
      – PersonEntity:
          Name:
            NameFull: Manam M
      – PersonEntity:
          Name:
            NameFull: MacConaill LE
      – PersonEntity:
          Name:
            NameFull: Ceca E
      – PersonEntity:
          Name:
            NameFull: Benich SN
      – PersonEntity:
          Name:
            NameFull: London WB
      – PersonEntity:
          Name:
            NameFull: Schilsky RL
      – PersonEntity:
          Name:
            NameFull: Bruinooge SS
      – PersonEntity:
          Name:
            NameFull: Guidry Auvil JM
      – PersonEntity:
          Name:
            NameFull: Cerami E
      – PersonEntity:
          Name:
            NameFull: Rollins BJ
      – PersonEntity:
          Name:
            NameFull: Meyerson ML
      – PersonEntity:
          Name:
            NameFull: Lindeman NI
      – PersonEntity:
          Name:
            NameFull: Johnson BE
      – PersonEntity:
          Name:
            NameFull: Cherniack AD
      – PersonEntity:
          Name:
            NameFull: Church AJ
      – PersonEntity:
          Name:
            NameFull: Janeway KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2024 Aug 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1